VRTXVERTEX PHARMACEUTICALS INC
CUSIP 92532F100 · common stock
5 tracked investors held VERTEX PHARMACEUTICALS INC (VRTX) at the end of Q3 2026, worth $50.1M in total. The largest holder was Joel Greenblatt, with 0.0% of its portfolio. Mario Gabelli opened a new position this quarter.
Holders · Q3 2026
5
New holders
1
Value held
$50.1M
Quarter-end price (est.)
$522.81
Investors holding VRTX · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Joel Greenblatt Gotham Asset Management, LLC | 0.03% | 33,266 | $17.4M | ADD+75.2% |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 28,676 | $15M | ADD+17.2% |
| Tweedy Browne Tweedy, Browne Co LLC | 1.11% | 26,013 | $13.6M | REDUCE-35.2% |
| Ron Baron BAMCO Inc. (Baron Capital) | 0.01% | 7,400 | $3.9M | ADD+23.3% |
| Mario Gabelli GAMCO Investors, Inc. | 0.00% | 400 | $209.1K | NEW |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Torray Funds | 1.02% | 15,215 | $7.6M | EXIT |